Health and Human Services Secretary Robert F. Kennedy Jr. has been critical of the drugs, instead placing a focus on ...

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump officials reject Medicare coverage ...

The proposal would have enabled more Americans to afford new medications in the GLP-1 class that have been shown to reduce weight.

The Centers for Medicare & Medicaid Services April 4 finalized changes to the Medicare Advantage and prescription drug ...

The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden ...

The Trump administration decided not to cover costly obesity treatments under Medicare's Part D. Despite a proposed rule by ...

Maxeon Solar Technologies said it is establishing an alternative network of supply-chain partners and increasing its manufacturing capabilities in the U.S. as it deals with new tariffs and trade ...

The Trump administration said Friday that Medicare and Medicaid won’t expand coverage of popular anti-obesity drugs, ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.